참고문헌
- Atoum M, Tchoporyan MN (2014). Association between circulatory vitamin D, Taq1 vitamin D receptor gene polymorphism and colorectal cancer risk among Jordanians. Asian Pac J Cancer Prev, 15, 7337-41. https://doi.org/10.7314/APJCP.2014.15.17.7337
- Baker, AR, McDonnell DP, Hughes M, et al (1988). Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA, 85, 3294-8. https://doi.org/10.1073/pnas.85.10.3294
- Brown, AJ, Dusso A, Slatopolsky E (1999). Vitamin D. Am J Physiol, 277, 157-75.
- Crofts La, Hancock MS, Morrison NA, Eisman JA (1998). Multiple promoters direct the tissue-specific expression of novel n-terminal variant human vitamin d receptor gene transcripts. Proc Natl Acad Sci USA, 95, 10529-34. https://doi.org/10.1073/pnas.95.18.10529
- Donkena KV, Young C (2011). Vitamin D, sunlight and prostate cancer risk. Adv Prev Med, 281863, 13.
- Grant WB. Vitamin D status: ready for guiding prostate cancer diagnosis and treatment. Clin Cancer Res, 20, 2241-3.
- Gross, C, Stamey T, Hancock S and Feldman D (1998). Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). J Urol, 159, 2035-9; 2039-40. https://doi.org/10.1016/S0022-5347(01)63236-1
- Guo Z, Wen J, Kan Q, et al (2013). Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects. Tumour Biol, 34, 3189-3200. https://doi.org/10.1007/s13277-013-0889-6
- Habuchi T, Suzuki T, Sasaki R, et al (2000). Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res, 60, 305-8.
- Haussler MR, Whitfield GK, Haussler CA, et al (1998). The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res, 13, 325-49. https://doi.org/10.1359/jbmr.1998.13.3.325
- Huang SP, Huang CY, Wu WJ, et al (2006). Association of Vitamin D receptor Fok1 polymorphism with prostate cancer risk, Clinico-pathological features and recurrence of prostate specific antigen after radical prostatectomy. Int J Cancer, 119, 1902-7. https://doi.org/10.1002/ijc.22053
- Hayes VM, Severi G, Padilla EJ, et al (2005). Genetic variants in the vitamin D receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 997-9. https://doi.org/10.1158/1055-9965.EPI-04-0660
- Holt SK, Kwon EM, Peters U, Ostrander EA, Stanford JL (2009). Vitamin D pathway gene variants and prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 18, 1929-33. https://doi.org/10.1158/1055-9965.EPI-09-0113
- Holund B (1980). Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol, 14, 29-35. https://doi.org/10.3109/00365598009181186
- Hughes, MR, Malloy PJ, Kieback DG, et al (1988). point mutations in the human vitamin d receptor gene associated with hypocalcemic rickets. Science 242, 1702-5. https://doi.org/10.1126/science.2849209
- Ingles, SA, Coetzee GA, Ross RK, et al (1998). Association of prostate cancer with vitamin D receptor haplotypes in African-Americans. Cancer Res, 58, 1620-3.
- Jemal A, Siegel R, Ward E, et al (2006) CA Cancer J Clin, 56, 106-30. https://doi.org/10.3322/canjclin.56.2.106
- Li H, Stampfer MJ, Hollis JB, et al (2007). A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer. PLoS Med, 4, 103. https://doi.org/10.1371/journal.pmed.0040103
- Li XY, Boudjelal M, Xiao JH, et al (1999). 1,25-Dihydroxyvitamin D3 increases nuclear Vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin." Mol Endocrinol 13, 1686-94. https://doi.org/10.1210/mend.13.10.0362
- Lichtenstein P, Holm NV, Verkasalo PK, et al (2000). Skytthe A and Hemminki K. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 343, 78-85. https://doi.org/10.1056/NEJM200007133430201
- Luong, KV and Nguyen LT (2010). The beneficial role of vitamin d and its analogs in cancer treatment and prevention. Crit Rev Oncol Hematol, 73, 192-201. https://doi.org/10.1016/j.critrevonc.2009.04.008
- Miller GJ, Stapleton GE, Ferrara JA, et al (1992). The human prostatic carcinoma cell line lncap expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3. Cancer Res, 52, 515-20.
- Nair RI, Maseeh A (2012). Vitamin D the sun shine vitamin. J Pharmacol Pharmacother. 3, 118-126.
- Nwosu V, Carpten J, Trent JM, Sheridan R (2001). Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet, 10, 2313-8. https://doi.org/10.1093/hmg/10.20.2313
- Oakley-Girvan I, Feldman D, Eccleshall TR, et al (2004). Risk of Early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Cancer Epidemiol Biomarkers Prev, 13, 1325-30.
- Parkin, DM, Bray FI, Devesa SS (2001). Cancer burden in the Year 2000. The global picture. Eur J Cancer, 37, 4-66.
- Peehl DM, Skowronski RJ, Leung GK, (1994). Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res, 54, 805-10.
- Polek, TC, Weigel NL. Vitamin D and prostate cancer (2002). J Androl, 23, 9-17.
- Saijo T, It M, Takeda E, et al (1991). A unique mutation in the vitamin d receptor gene in three japanese patients with vitamin d-dependent rickets type ii: utility of single-strand conformation polymorphism analysis for heterozygous carrier detection. Am J Hum Genet, 49, 668-73.
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013 CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Tzonou A, Signorello LB, Lagiou P, et al (1999). Diet and cancer of the prostate: a case-control study in Greece. Int J Cancer, 80, 704-8. https://doi.org/10.1002/(SICI)1097-0215(19990301)80:5<704::AID-IJC13>3.0.CO;2-Z
- Wu-Wong JR (2007). Vitamin D receptor: a highly versatile nuclear receptor. Kidney Int, 72, 237-9. https://doi.org/10.1038/sj.ki.5002428
- Xu J, Zheng SL, Komiya A, et al (2003). Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am J Hum Genet, 72, 208-12. https://doi.org/10.1086/345802
- Yin, M, Wei S and Wei Q (2009). Vitamin D receptor genetic polymorphisms and prostate cancer risk: A meta-analysis of 36 published studies. Int J Clin Exp Med, 2, 159-75.
- Yousaf N, Afzal S, Hayat T,et al (2014). Association of vitamin D receptor gene polymorphism with prostate cancer risk in Pakistani population. Asian Pac J Cancer Prev, 15, 10009-13. https://doi.org/10.7314/APJCP.2014.15.22.10009
- Yu, S. and Cantorna MT (2011). Epigenetic reduction in invariant nkt cells following in utero vitamin d deficiency in mice. J Immunol, 186, 1384-90. https://doi.org/10.4049/jimmunol.1002545
- Zhang X, Ho SM (2011). Epigenetics meets endocrinology. J Mol Endocrinol, 46, 11-32. https://doi.org/10.1677/JME-10-0053
- Zhang Q, Shan Y (2013). Genetic polymorphism of vitamin D receptor and risk of prostate cancer: a meta -analysis. J Boun, 18, 961-9.
피인용 문헌
- Preventive Effects of Aspirin on Cardiovascular Complications in Prostate Cancer Cases after Endocrinotherapy vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4909
- Association of FokI polymorphism of vitamin D receptor with urothelial bladder cancer in Tunisians: role of tobacco smoking and plasma vitamin D concentration vol.37, pp.5, 2016, https://doi.org/10.1007/s13277-015-4496-6
- gene polymorphism with sex- and non-sex-associated cancers: A meta-analysis vol.39, pp.10, 2017, https://doi.org/10.1177/1010428317727164
- Genetics of Obstructive Sleep Apnea: Vitamin D Receptor Gene Variation Affects Both Vitamin D Serum Concentration and Disease Susceptibility vol.23, pp.1, 2019, https://doi.org/10.1089/omi.2018.0184